Newron Pharmaceuticals SpA's total assets for Q2 2025 were €61.39M, a decrease of -3.93% from the previous quarter. CH:NWRN total liabilities were €59.81M for the fiscal quarter, a -4.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.